Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Original Article

J.P. Frías, M.J. Davies, J. Rosenstock, F.C.P. Manghi, L.F. Landó, B.K. Bergman, B. Liu, X. Cui, and K. Brown

N Engl J Med 2021;385:503-515

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
08/04/2021
Course expires: 
08/05/2023

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, August 5, 2023 - 11:59pm.